Medtronic’s Simplera Sync glucose sensor has been FDA-approved for use with its 780G insulin pumps, marking a key step in the company’s push to grow its diabetes business through smarter, more integrated insulin delivery.

The FDA issued an early alert for BD’s PowerPICC catheters due to cracking and leakage risks, prompting a recall after reports of 10 serious injuries linked to material fatigue.

Field Medical raised $40 million to advance its pulsed field ablation technology for ventricular tachycardia, aiming to address a major unmet need in cardiac arrhythmia treatment.